Skin Biopsy Market is Expected to Grow at a CAGR over 9.89% from 2022 to 2030

Pune, India, November, 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the global skin biopsy market.

Market Highlights

 The global skin biopsy market is expected to reach USD 162.7 Million at a CAGR of 9.89% during the forecast period 2022-2030.

Skin biopsy is a procedure for the diagnosis of number of skin diseases such as melanoma, dermatitis and various skin infections. Cancer is becoming one of the major problems across the globe and skin cancer is considered as one of the most common type of cancer. In more than 90% cases, skin cancer is caused by the exposure to ultraviolet radiation from the sun.

Increasing prevalence of skin diseases, rising awareness about skin cancer and it treatment, and growing demand for technologically advanced medical devices are major drivers for the market growth. High cost of skin biopsy might restrain the market growth in developing regions across the globe.

Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Skin biopsy market research report–Global forecast till 2030.”

Major Players in Skin biopsy Market:

Some of the key players in the global market are Boston Scientific Corporation (U.S.), COOK Medical (U.S.), BD (U.S.), DTR Medical Ltd (U.K), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), Gallini Srl (Italy), Hologic, Inc. (U.S.), and Cardinal Health (U.S.).

Regional Analysis

According to the World Health Organization (WHO), the global incidence of melanoma is increasing continuously and the growth is attributed to the recreational exposure to the sun and a history of sunburn.

America is the largest market for skin biopsy owing to rising prevalence of skin diseases in the U.S., and demand for new treatment methods. The presence of large companies, and good reimbursement scenario in the U.S. is also drives the growth of the market. According to Skin Cancer Foundation Statistics, one in every five Americans will develop skin cancer in their lifetime.

Europe has secured the second position in the skin biopsy market owing to the steady rise in the prevalence of skin diseases and rising number of diagnostic services.

Asia Pacific skin cancer market is driven by increasing prevalence of skin cancer, presence of developing economies, and increasing government support. While adverse effect associated with treatment, long approval time for the drugs and strict regulatory rules has restrain the growth of the market. There is also a demand for the innovative technologies for the diagnosis of various skin diseases and cancer, supporting the market growth.

The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Skin Biopsy Market Research Report

Segmentation

The global skin biopsy market is segmented on the basis of type, devices, indication, and end user.

On the basis of type, market is segmented into shave biopsy, punch biopsy, excisional biopsy and incisional biopsy.

On the basis of devices, the market is segmented into needle based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles and others.

On the basis of indication, the market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others.

 Skin infection is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.

On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.